About Inventia Life Science
Inventia Life Science is a company based in Sydney (Australia) founded in 2013 by Cameron Ferris, Julio Ribeiro, and Aidan O'Mahony. Inventia Life Science has raised $41 million across 5 funding rounds from investors including Superfund, Blackbird Ventures and Skip Capital. Inventia Life Science offers products and services including RASTRUM™ Allegro, RASTRUM™ Cloud, and RASTRUM™ Matrices. Inventia Life Science operates in a competitive market with competitors including Nuclera Nucleics, Aspect Biosystems, CELLINK, Collplant and ROKIT Healthcare, among others.
- Headquarter Sydney, Australia
- Founders Cameron Ferris, Julio Ribeiro, Aidan O'Mahony
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$41 M (USD)
in 5 rounds
-
Latest Funding Round
$4.4 M (USD), Series B
Jun 01, 2022
-
Investors
Superfund
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inventia Life Science
Inventia Life Science offers a comprehensive portfolio of products and services, including RASTRUM™ Allegro, RASTRUM™ Cloud, and RASTRUM™ Matrices.
Enables rapid production of scalable 3D cell models for research.
Provides architectures for managing and analyzing cell models online.
Offers tunable environments for 3D cell culture applications.
People of Inventia Life Science
Unlock access to complete
Funding Insights of Inventia Life Science
Inventia Life Science has successfully raised a total of $41M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $4.4 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Inventia Life Science
Inventia Life Science has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Superfund, Blackbird Ventures and Skip Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in seed, early, and later-stage tech companies.
|
Locked | Locked | Locked | |
|
Tech-focused VC firm primarily investing in early to late-stage startups
|
Locked | Locked | Locked | |
|
Investments are directed toward early-stage tech startups by AirTree.
|
Locked | Locked | Locked |
Investor details for Inventia Life Science
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inventia Life Science
Investment portfolio details for Inventia Life Science
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Inventia Life Science
Detailed financials for Inventia Life Science
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inventia Life Science Comparisons
Peer comparison for Inventia Life Science
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Inventia Life Science
Inventia Life Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, Aspect Biosystems, CELLINK, Collplant and ROKIT Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Desktop bioprinter for genes and proteins production is developed.
|
|
| Locked | Locked | Locked |
Bioprinting technology and tissue therapeutics for regenerative medicine are developed.
|
|
| Locked | Locked | Locked |
3D bioprinters and bioinks are developed for research applications.
|
|
| Locked | Locked | Locked |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| Locked | Locked | Locked |
4D bio-printer solutions for tissue regeneration are provided.
|
|
| Locked | Locked | Locked |
Provider of 3D printing pharmaceutical technology platform for drug design
|
Detailed competitors of Inventia Life Science
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inventia Life Science
Complete news archive for Inventia Life Science
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inventia Life Science
Inventia Life Science was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Inventia Life Science is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Julio Ribeiro is the current CEO of Inventia Life Science. They have also founded this company.
Inventia Life Science is a funded company, having raised a total of $41M across 5 funding rounds to date.
Inventia Life Science was founded in 2013 in Sydney, Australia, within the biotechnology sector. 3D bio-printers are developed by the company for applications in biomedical research and drug discovery. Human cells are printed using a platform that incorporates natural and synthetic hydrogel bio-inks. This technology supports 3D cell biology studies, including cancer drug testing, through digital bio-printing methods. Operations focus on advancing research tools for scientific and pharmaceutical uses.
Inventia Life Science's top competitors include Nuclera Nucleics, Aspect Biosystems and Allevi.
Inventia Life Science offers RASTRUM™ Allegro, RASTRUM™ Cloud, and RASTRUM™ Matrices.
Inventia Life Science has 6 investors. Key investors include Superfund, Blackbird Ventures, Skip Capital, AirTree, and Main Sequence.